Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Allogene Therapeutics Inc (ALLO)

Allogene Therapeutics Inc (ALLO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Allogene Therapeutics Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for ALLO-316, an AlloCAR Tâ„¢ Investigational Product for Adult Patients with Advanced or Metastatic Renal Cell Carcinoma (RCC)

ALLO : 2.80 (+4.48%)
Why is Wall Street So Bullish About These 2 Russell 2000 Stocks?

These smaller, rapidly expanding companies have significant growth potential.

ALLO : 2.80 (+4.48%)
$SPX : 5,832.92 (+0.16%)
IIPR : 133.75 (+0.21%)
GTBIF : 10.2300 (-4.12%)
CRLBF : 1.5300 (-3.16%)
TCNNF : 11.5000 (-11.88%)
Allogene Therapeutics: Q2 Earnings Snapshot

Allogene Therapeutics: Q2 Earnings Snapshot

ALLO : 2.80 (+4.48%)
Allogene Therapeutics: Q1 Earnings Snapshot

Allogene Therapeutics: Q1 Earnings Snapshot

ALLO : 2.80 (+4.48%)
Allogene Therapeutics: Q4 Earnings Snapshot

Allogene Therapeutics: Q4 Earnings Snapshot

ALLO : 2.80 (+4.48%)
Allogene Therapeutics: Q3 Earnings Snapshot

Allogene Therapeutics: Q3 Earnings Snapshot

ALLO : 2.80 (+4.48%)
A Bull Market Is Coming: 1 Beaten-Down Growth Stock You Could Regret Not Buying on the Dip

Wall Street price targets suggest this stock can rocket more than 400% higher.

CRBU : 1.9300 (+2.66%)
ALLO : 2.80 (+4.48%)
GILD : 88.08 (-0.77%)
Cantor Fitzgerald Bolsters Healthcare and Biotechnology Equity Research Team with Addition of Josh Schimmer, M.D., and Eric Schmidt, Ph.D.

/PRNewswire/ -- Cantor Fitzgerald, L.P., ("Cantor") a leading global financial services firm, today announced the addition of Josh Schimmer, M.D., and Eric...

ALLO : 2.80 (+4.48%)
Allogene Therapeutics: Q2 Earnings Snapshot

Allogene Therapeutics: Q2 Earnings Snapshot

ALLO : 2.80 (+4.48%)
3 Stocks With Sky-High Short Interest Levels

BYND, BTAI, and ALLO stand out as high short-interest stocks to watch due to their potential for price fluctuations and short-squeeze opportunities.

BTAI : 0.7108 (+6.57%)
BYND : 6.29 (-4.41%)
ALLO : 2.80 (+4.48%)
CVNA : 208.74 (+1.81%)
RIVN : 10.47 (-3.59%)
ENVX : 10.63 (-6.84%)

Barchart Exclusives

2 Promising Growth Stocks to Buy and Hold for a Decade or Longer
These two growth stocks could be great additions to a long-term buy-and-hold portfolio. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar